Eating Disorders News and Research

Latest Eating Disorders News and Research

Girls who eat with their families at mealtimes avoid eating disorders

A new study has found that teenage girls who eat meals with their families are more likely to avoid eating disorders such as bulimia.

8 Jan 2008

Plan ahead for holiday meals with persons who have eating disorders

Holiday celebrations focused on food are difficult for persons recovering from eating disorders, and challenging for their family and friends.

14 Dec 2007

University of Sydney to lead international anorexia study

An international treatment trial for sufferers of chronic anorexia nervosa involving Sydney, London and Chicago is a world first.

5 Dec 2007

Anorexia begins in the womb

New research is suggesting that a male twin who shares the womb with a female twin is almost as likely as twin girls to be diagnosed with anorexia.

5 Dec 2007

Positive results from trial of investigational anti-epilepsy drug Brivaracetam

UCB has announced data demonstrating that anti-epileptic drug (AED) brivaracetam, with the proposed trade name Rikelta, administered as an adjunctive treatment in adults with refractory epilepsy with partial onset seizures, significantly reduced seizure frequency and had a side-effect profile comparable to placebo.

4 Dec 2007

Males with a twin sister appear more likely to develop the eating disorder anorexia nervosa

Males who have a twin sister appear more likely to develop the eating disorder anorexia nervosa than other males, including those with a twin brother, according to a report in the December issue of Archives of General Psychiatry.

4 Dec 2007

Brain patterns of former anorexics reveal clues to disorder's lasting impact

Even after more than a year of maintaining a normalized body weight, young women who recovered from anorexia nervosa show vastly different patterns of brain activity compared to similar women without the eating disorder, Walter H. Kaye, M.D., professor of psychiatry, University of Pittsburgh School of Medicine, and colleagues report in the December issue of the American Journal of Psychiatry.

2 Dec 2007

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.

19 Nov 2007

Increase in eating disorder symptoms among ethnic groups

Eating disorders in the U.S. among ethnic groups were thought to be rare, but recent studies have shown that many cultures are now exposed to the thin beauty ideal.

19 Nov 2007

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Genentech, Inc. has announced that both study arms of a randomized, multi-center Phase II clinical study of Avastin (bevacizumab) administered alone or in combination with irinotecan chemotherapy demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.

19 Nov 2007

Modafinil effective treatment for excessive sleepiness

A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that modafinil is well-tolerated in the treatment of excessive sleepiness associated with disorders of sleep and wakefulness such as shift work sleep disorder, obstructive sleep apnea (OSA) and narcolepsy, and does not affect cardiovascular or sleep parameters.

16 Oct 2007

20% of bariatric surgery candidates not psychologically cleared for surgery

A new study by Rhode Island Hospital and Brown University researchers reported that 18 percent of 500 candidates for bariatric surgery did not receive the initial psychiatric clearance for the surgery.

16 Oct 2007

Anorexia as addictive as ectasy

French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways

4 Oct 2007

Taxotere (docetaxel) granted FDA approval to treat locally advanced head and neck cancer prior to chemo and surgery

Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.

2 Oct 2007